Clinical performance of the fully automated quantitative LeaDEA Pneumocystis PCR Kit for the diagnosis of Pneumocystis jirovecii pneumonia

Clicks: 10
ID: 315881
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #148 of 172 articles by views in medical mycology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 172 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Compared with microscopy, quantitative real-time PCR (qPCR) is more sensitive for the diagnosis of Pneumocystis jirovecii pneumonia (PcP) and may also help distinguish PcP from colonization based on fungal burden. In this retrospective cohort study, we evaluated the performance of the LeaDEA Pneumocystis PCR Kit, a single-packaged reagent system designed for use on a fully automated molecular testing platform, using respiratory specimens from immunocompromised patients. The analytical and clinical performance of the LeaDEA assay on the GeneLEAD VIII platform was compared with that of a previously described laboratory-developed reference qPCR assay targeting the major surface glycoprotein gene of P. jirovecii. The limit of detection was 500 copies/mL for both assays, with a quantification range of 10³-10⁸ copies/mL. Among 350 patients (158 bronchoalveolar lavage and 192 sputum [including induced sputum] samples), the reference assay-based EORTC/MSGERC criteria classified 162 as having PcP (13 proven and 149 probable) and 188 as non-PcP. The overall concordance of qPCR results between the assays was 93% (kappa, 0.85). Compared with the reference assay-based diagnoses, the LeaDEA assay-based diagnoses showed 92.0% positive percent agreement and 96.3% negative percent agreement (kappa, 0.88). Among the PCR-positive non-HIV patients, the copy numbers measured by the LeaDEA assay distinguished PcP from colonization based on qPCR-independent diagnoses, with 63.8% sensitivity and 72.5% specificity, at an optimal cutoff of 20,427 copies/mL. The LeaDEA assay demonstrated analytical and clinical performance comparable to that of a reference qPCR assay, which may facilitate the diagnosis of PcP in routine clinical laboratories.
Reference Key
openalex_W7163515733 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yasufumi Matsumura, Yasuhiro Tsuchido, Yusuke Tsuda, Koh Shinohara, Masaki Yamamoto, Miki Nagao
Journal medical mycology
Year 2026
DOI
10.1093/mmy/myag058
URL
https://doi.org/10.1093/mmy/myag058
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.